Loading clinical trials...
Loading clinical trials...
Idiopathic Interstitial Pneumopathy : Genetic and Environmental Determinants From Infancy to Elderly
The main objective is to describe the phenotypic features of the paediatric and adult patients with Idiopathic Interstitial Pneumopathy/Pneumopathy Interstitial Diffuse (IIP/PID), at diagnosis and during the follow-up. These data will be critical for the description of the natural history of the various forms of IIP/PID.
The French RaDiCo-PID : Idiopathic Interstitial Pneumopathy registry is an ongoing observational prospective and retrospective cohort with longitudinal long-term follow-up includes pediatric and adult patients with Idiopathic Interstitial Lung Disease (ILD) from the reference and competence centers.
Age
All ages
Sex
ALL
Healthy Volunteers
No
CHU Lyon - Hôpital Louis Pradel
Bron, France
AP-HP - Hôpital Armand Trousseau
Paris, France
Start Date
June 21, 2017
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
April 4, 2025
2,500
ESTIMATED participants
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions